Cargando…
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
The blood–brain barrier (BBB), built by brain endothelial cells (BECs), is impermeable to biologics. Liposomes and other nanoparticles are good candidates for the delivery of biologics across the BECs, as they can encapsulate numerous molecules of interest in an omnipotent manner. The liposomes need...
Autores principales: | Thomsen, Maj Schneider, Johnsen, Kasper Bendix, Kucharz, Krzysztof, Lauritzen, Martin, Moos, Torben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608573/ https://www.ncbi.nlm.nih.gov/pubmed/36297671 http://dx.doi.org/10.3390/pharmaceutics14102237 |
Ejemplares similares
-
Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles
por: Johnsen, Kasper Bendix, et al.
Publicado: (2018) -
Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma
por: Johnsen, Kasper Bendix, et al.
Publicado: (2017) -
Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles
por: Kucharz, Krzysztof, et al.
Publicado: (2021) -
Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology
por: Skjørringe, Tina, et al.
Publicado: (2015) -
The blood-brain barrier studied in vitro across species
por: Thomsen, Maj Schneider, et al.
Publicado: (2021)